Market News
Recent Developments
New product launches
- In 2022, Innophos introduced a new grade of calcium hypophosphite specifically designed for the pharmaceutical industry. This new grade is known for its enhanced purity and consistency, making it well-suited for the manufacturing of various medicines. The improved qualities of this grade enable pharmaceutical manufacturers to ensure high-quality products.
- In 2021, AkzoNobel launched a new range of calcium hypophosphite products targeting the poultry industry. These products are specifically formulated to be highly effective in preventing and treating coccidiosis, a common disease in poultry. The introduction of these new products provides poultry farmers with improved solutions to address the health and well-being of their flocks.
- LANXESS, in 2020, introduced a new grade of calcium hypophosphite that caters to the industrial sector. This new grade stands out due to its increased stability and resistance to degradation compared to previous grades. The enhanced properties make it suitable for various industrial applications, providing manufacturers with a reliable and high-performing option for their specific needs.
Acquisition and partnerships
- Innophos: Acquired the calcium hypophosphite business of Solvay in 2022. This acquisition expanded Innophos's product portfolio and gave it a larger market share in the calcium hypophosphite market.
- LANXESS: Partnered with Weifang Guorun Chemical in 2021 to establish a joint venture for the production of calcium hypophosphite in China. This partnership gave LANXESS access to Weifang Guorun Chemical's production facilities and expertise in the Chinese market.
- AkzoNobel: Acquired the calcium hypophosphite business of Aditya Birla Chemicals in 2020. This acquisition expanded AkzoNobel's product portfolio and gave it a larger market share in the calcium hypophosphite market.